Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6421
    -0.0004 (-0.07%)
     
  • OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD

    2,406.70
    +8.70 (+0.36%)
     
  • Bitcoin AUD

    99,311.23
    +363.40 (+0.37%)
     
  • CMC Crypto 200

    1,367.36
    +54.74 (+4.17%)
     
  • AUD/EUR

    0.6023
    -0.0008 (-0.13%)
     
  • AUD/NZD

    1.0893
    +0.0018 (+0.17%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,037.65
    -356.67 (-2.05%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • Dow Jones

    37,986.40
    +211.02 (+0.56%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

If You Bought 100 Shares of Johnson & Johnson 10 Years Ago, This Is How Much You Would Have Today

If You Bought 100 Shares of Johnson & Johnson 10 Years Ago, This Is How Much You Would Have Today

The stability of Johnson & Johnson (NYSE: JNJ) has attracted investors for a long time. The healthcare company with more than 140,000 employees is a Dividend King that has raised its quarterly dividend annually for 60 consecutive years, including a 6.6% bump this year to $1.13 per share, resulting in a yield of about 2.58%. The company has built-in diversity because it is so large and operates in three segments: pharmaceuticals, medtech, and consumer healthcare.